LabVantage Named a Visionary Leader in Life Sciences and Industrial LIMS by Frost & Sullivan
21.9.2026 10:30:00 CEST | Business Wire | Press release
— Dual recognition in 2026 Frost Radar™ reports marks a fourth consecutive year of Frost Radar leadership — — Frost & Sullivan cited LabVantage CORTEX™ (for life sciences) and LIMS deployments spanning food and beverage, oil and gas, forensics, and government laboratories (for other industrial applications) —
LabVantage Solutions, Inc., a leading global provider of laboratory informatics solutions and services, has been named a Visionary Leader in two 2026 Frost Radar™ reports by Frost & Sullivan: Frost Radar™: Life Sciences Laboratory Information Management Systems, 2026 and Frost Radar™: Laboratory Information Management Systems in Industrial Applications, 2026. Announced at LabVantage’s Customer Training and Education Conference (CTEC) Europe 2026 in Paris, the dual recognition marks LabVantage’s fourth consecutive year of Frost Radar leadership.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260921487430/en/
The Frost Radar is an independent benchmarking analysis that evaluates companies on a Growth Index and an Innovation Index. The Growth Index measures a company’s growth performance, track record, and ability to execute its growth strategy, while the Innovation Index assesses its ability to develop globally applicable solutions that evolve with changing customer needs. For the 2026 assessments, Frost & Sullivan benchmarked 16 companies in life sciences and screened 50 vendors in industrial applications, plotting the top 10. LabVantage placed as a Visionary Leader in both.
“LabVantage is the first enterprise LIMS vendor to offer a comprehensive agentic AI framework, called LabVantage CORTEX,” said Anantharaman Viswanathan, Research Director, Frost & Sullivan. “By building LabVantage CORTEX separately from the validated LIMS core, the company allows AI capabilities to evolve quickly without disrupting regulated operations. Combined with a broad footprint across industries well beyond life sciences and strong, double-digit growth in the LIMS market, this earns LabVantage a Visionary Leader position in both of our 2026 LIMS Frost Radar assessments.”
In its life sciences evaluation, Frost & Sullivan highlighted LabVantage’s configurable, browser-based platform, which integrates LIMS, electronic laboratory notebook (ELN), laboratory execution system (LES), scientific data management system (SDMS), and advanced analytics. The report noted that LabVantage CORTEX extends the company’s position from traditional LIMS to AI-enabled laboratory intelligence and enables traceable, auditable AI within laboratory workflows. It also recognized more than 40 years of regulatory expertise, growing SaaS adoption, and customer retention above 98%.
The industrial applications report focused on LabVantage’s footprint beyond life sciences, including food and beverage, oil and gas, consumer goods, forensics, and government laboratories. Frost & Sullivan identified this breadth as a key driver of the company’s strong, double-digit growth in the LIMS market. The report also noted LabVantage’s investments in cybersecurity and compliance, as well as its approach to augmentation over full automation or dark laboratories. This reflects LabVantage’s human-in-the-loop model, in which robotics, automation, and agentic AI support the scaling of routine workflows while scientists retain interpretation and critical decisions.
“I value nothing more than independent validation from the clients and the everyday heroes in the lab,” said Mikael Hagstroem, Chief Executive Officer at LabVantage Solutions. “Offering a trusted agentic AI environment for high-stakes, regulated industries is a proud milestone, and I am incredibly grateful to my colleagues for launching LabVantage CORTEX. Built in collaboration with leading global laboratories, CORTEX delivers relevant and impactful agentic AI that gives scientists trusted auditable automation without compromising compliance or data integrity. Celebrating our fourth consecutive year of Frost Radar leadership at CTEC Europe is the perfect way to honor the customer-led innovation that drives us forward.”
The Frost & Sullivan summary reports are available at this link. For more information on LabVantage and LabVantage CORTEX, visit www.labvantage.com or email info@labvantage.com.
About LabVantage Solutions
LabVantage Solutions is a global leader in laboratory informatics, driving digital transformation through LabVantage CORTEX™. This AI, analytics, and automation platform unifies LIMS, ELN, LES, SDMS, and analytics in a 100% browser-based environment with agentic AI. With 40+ years of LIMS expertise and 1,500+ customers across industries, LabVantage helps streamline workflows and support compliance. Headquartered in Somerset, New Jersey, LabVantage serves customers worldwide through global teams, regional offices, and partners. Learn more at www.labvantage.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260921487430/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Announces Third Quarter 2026 Financial Results and Business Updates5.11.2026 12:00:00 CET | Press release
Total global revenues of $1.9 billion for the third quarter, an increase of 34% from the prior yearBRUKINSA (zanubrutinib) global revenues of $1.4 billion for the third quarter, an increase of 34% from the prior yearDiluted GAAP Earnings per American Depository Share (ADS) of $3.28 for the third quarter; non-GAAP diluted Earnings per ADS of $4.59 for the third quarterRaised 2026 total revenue guidance to $6.9 to $7.0 billion; GAAP operating income of $1.2 to $1.3 billion, non-GAAP operating income of $1.9 to $2.0 billion BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced financial results and corporate updates from the third quarter of 2026. John V. Oyler, Co-Founder, Chairman, and CEO, BeOne, said: “Our strong third quarter results and raised full-year guidance reflect continued rapid global growth and leadership in hematology, anchored by our foundational BTK inhibitor BRUKINSA, which drives powerful and sustained responses in pat
Sugar Taxes Under Scrutiny: New Competere Study Questions Health Outcomes and Warns of Unintended Consequences5.11.2026 12:00:00 CET | Press release
The science-based policy paper examines sugar taxes, warning labels, and reformulation, distinguishing changes in purchasing behavior from demonstrated health improvements and calling for smarter prevention. As governments debate sugar taxation and nutrition measures, a new policy paper asks a critical question: Do these interventions deliver lasting health improvements, for whom, and at what cost? Published by Competere with the support of the Association of Latin American Sugar Producers (UNALA), Understanding Sugar Beyond the Narrative – by Pietro Paganini – offers policymakers, journalists, and consumers an accessible guide to sugar’s role in health, sustainability, and the global economy. Combining scientific evidence with economic and policy analysis, the paper challenges common misconceptions and examines whether taxation, warning labels, and reformulation deliver measurable health benefits. While sugar taxes can influence prices, purchases, and product composition, evidence of
Klarna Goes Global With Anti-Scam Call Verification5.11.2026 11:52:00 CET | Press release
Klarna, the everyday finance network, today announced its popular in-app Call Status Detection tool is now live globally, giving consumers a reliable and simple way to check whether someone calling them is genuinely from Klarna. Call Status Detection has already helped thousands of consumers verify calls since it launched in the Nordics in September. The feature has now been rolled out globally, reflecting Klarna’s commitment to protecting its customers from fraud. Call Status Detection is quick and easy to use by design. If a customer takes a call from someone claiming to be Klarna, all they have to do is open the Klarna app and check the banner at the top of their screen — green means the call is verified and it is safe to continue, while amber means Klarna cannot verify the call and the customer should hang up. The feature builds on Klarna’s existing anti-fraud measures like the Klarna Inbox, which enables verification of written communication like emails, texts and letters, and aim
Prodalim Acquires South Africa’s Brenn-O-Kem, Expanding Its Global Circular Economy Platform with High-Value Grape-Based Specialty Ingredients5.11.2026 11:17:00 CET | Press release
Prodalim announced the acquisition of Brenn-O-Kem (BOK), a South African leader in upcycling winery by-products into high-value specialty ingredients for the wine, food and beverage, nutraceutical, agricultural and pharmaceutical industries. The acquisition strengthens Prodalim’s global circular economy platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261103526127/en/ BOK transforms grape pomace and wine lees into a broad portfolio of natural, clean-label ingredients, including recycled aromatic alcohol for the wine and spirits industry; tartaric acid and derivatives for food, beverage and pharmaceutical applications; grape seed extracts for nutraceuticals; grape skin extracts for natural colors; grape seed oils and wine concentrates for culinary applications; and recycled compost for animal nutrition. Prodalim will acquire 93.25% of BOK for 37M USD. Founded in 1968, BOK operates three production sites in South Afric
SES Delivers Solid 9 Months & Q3 2026 Results and Reiterates Full-Year Outlook5.11.2026 10:22:00 CET | Press release
SES S.A. announces financial results for the nine and three months ended September 30, 2026. YTD 2026 Performance (€ million) YTD 2026 as reported (1) YTD 2025 as reported (1)(5) ∆ At constant FX (2) YTD 2025 like-for-like(3) ∆ At constant FX (2) Average €/$ FX rate 1.16 1.11 1.11 Revenue 2,472 1,743 +45.5% 2,628 -2.0% Adjusted EBITDA (4) 1,138 838 +40.0% 1,170 +1.4% 1) ‘Reported basis’ with Intelsat fully consolidated from July 17, 2025 2) ‘At constant FX’ refers to comparative figures restated at the current period FX rates to neutralize currency variations 3) ‘Like-for-like basis’ is as if Intelsat was fully consolidated from January 1, 2024 4) Excluding operating expenses/income recognized in relation to U.S. C-band repurposing, other income non-recurring, fair value movement on contingent value rights and other significant special items (disclosed separately) 5) 2025 has been restated to reflect Purchase Price Allocation (PPA) adjustments recorded in connection with the acquisitio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom